| 
   | 
    
  
  
 Vaccine Detail
                        
                          
                            | 
                              S. pyogenes SfbI Protein Vaccine                               | 
                           
                          
                            | Vaccine Information | 
                           
                          
                            
							
							  - Vaccine Name: S. pyogenes SfbI Protein Vaccine
 
					- Target Pathogen: Streptococcus pyogenes
 
					- Target Disease: Group A streptococcal infections, Strep throat, Scarlet fever
 
                              - Vaccine Ontology ID: VO_0004056
 
                              - Type: Subunit vaccine
 
                              - Status: Research
 
                              - Antigen: Recombinant SfbI protein
 
                          - SfbI
                            gene engineering:                            
                            
                              - Type: Recombinant protein preparation
 
                              - Description: 
 
                              - Detailed Gene Information: Click Here.
 
                             
						 
	
                          - Adjuvant: cholera toxin B subunit vaccine adjuvant
                            
						
 
              
 					
	     	 	                      
                                   - Immunization Route: intranasal immunization
 
							 
                           | 
                           
                          
                            | Host Response | 
                           
                          
                            | 
                           Mouse Response  
                            
                              - Host Strain: BALB/c
 
                              - Vaccination Protocol: MIce were immunized intranasally with 20 μL of SfbI (H2 fragment) covalently coupled to CTB or with CTB alone as a control on days 1, 3, 5, and 26 (30 mg/dose) (Guzmán et al., 1999).
 
                              - Challenge Protocol: On day 36 mice were challenged with 10^6 cfu of S. pyogenes DSM 2071 or NS239, respectively (Guzmán et al., 1999).
 
                              - Efficacy: SfbI-vaccinated animals showed 80% and 90% protection against homologous and heterologous challenge (Guzmán et al., 1999).
 
				
					
                             
						 | 
                           
                
                  | References  | 
                 
						  
                            
							                                                                Guzmán et al., 1999: Guzmán CA, Talay SR, Molinari G, Medina E, Chhatwal GS. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. The Journal of infectious diseases. 1999; 179(4); 901-906. [PubMed: 10068585]. 
                                                                                           | 
                           
 
                        
 
     |